Anti-CD154 or CTLA4lg obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance.

被引:92
作者
Wekerle, T
Sayegh, MH
Ito, H
Hill, J
Chandraker, A
Pearson, DA
Swenson, KG
Zhao, GL
Sykes, M
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med,Transplantat Biol Res Ctr, Bone Marrow Transplantat Sect, Boston, MA 02129 USA
[2] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Lab Immunogenet & Transplantat, Boston, MA 02115 USA
关键词
D O I
10.1097/00007890-199911150-00022
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Thymic irradiation (TI) or repeated administration of T cell-depleting monoclonal antibodies (TCD mAbs) is required in a previously described non-myeloablative regimen allowing allogeneic marrow engraftment with stable mixed chimerism and tolerance, As both treatments might be associated with toxicity in the clinical setting, we evaluated whether T-cell costimulatory blockade could be used to replace them. Methods. C57BL/6 mice received depleting anti-CD4 and anti-CD8 mAbs on day -5, 3 Gy whole body irradiation (day 0), and 15x10(6) fully MHC-mismatched, B10.A bone marrow cells. In addition, hosts were injected with an anti-CD154 mAb (day 0) and/or CTLA4Ig (day +2), Chimerism in peripheral blood was followed by flow cytometric (FACS) analysis, and tolerance was assessed by skin grafting, and also by mixed lymphocyte reaction (MLR) and cell-mediated lympholysis (CML) assays. The frequency of certain V beta families was determined by FACS to assess deletion of donor-reactive T cells. Results, Chimerism was transient and tolerance was not present in animals receiving TCD mAbs on day -5 without costimulatory blockade. The addition of anti-CD154 and CTLA4Ig, alone or in combination, reliably permitted induction of high levels of stable (>6 months) multi-lineage chimerism, with specific tolerance to skin grafts and donor antigens by MLR and CML assays. Long-term chimeras showed deletion of donor-reactive CD4(+) peripheral blood lymphocytes, splenocytes, and mature thymocytes, Administration of TCD mAbs only 1 day before bone marrow transplantation plus anti-CD154 also allowed induction of permanent chimerism and tolerance, Conclusions. One injection of anti-CD154 or CTLA4Ig overcomes the need for TI or prolonged host TCD in a preclinical model for the induction of mixed chimerism and deletional tolerance and thus further decreases the toxicity of this protocol. Achievement of tolerance with conditioning given over 24 hr suggests applicability to cadaveric organ transplantation.
引用
收藏
页码:1348 / 1355
页数:8
相关论文
共 51 条
[1]   MLS - A RETROVIRUS EXPLOITS THE IMMUNE-SYSTEM [J].
ACHAORBEA, H ;
PALMER, E .
IMMUNOLOGY TODAY, 1991, 12 (10) :356-361
[2]   THE MHC MOLECULE I-E IS NECESSARY BUT NOT SUFFICIENT FOR THE CLONAL DELETION OF V-BETA-11-BEARING T-CELLS [J].
BILL, J ;
KANAGAWA, O ;
WOODLAND, DL ;
PALMER, E .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (04) :1405-1419
[3]   Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo [J].
Brocker, T ;
Riedinger, M ;
Karjalainen, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (03) :541-550
[4]   Thymocyte development is normal in CTLA-4-deficient mice [J].
Chambers, CA ;
Cado, D ;
Truong, T ;
Allison, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (17) :9296-9301
[5]  
Colson YL, 1996, J IMMUNOL, V157, P2820
[6]   Mechanism for cotolerance in nonlethally conditioned mixed chimeras: Negative selection of the V-beta T-cell receptor repertoire by both host and donor bone marrow-derived cells [J].
Colson, YL ;
Lange, J ;
Fowler, K ;
Ildstad, ST .
BLOOD, 1996, 88 (12) :4601-4610
[7]  
DEGERMANN S, 1994, J IMMUNOL, V152, P3254
[8]   GENES ENCODING LIGANDS FOR DELETION OF V-BETA-11 T-CELLS COSEGREGATE WITH MAMMARY-TUMOR VIRUS GENOMES [J].
DYSON, PJ ;
KNIGHT, AM ;
FAIRCHILD, S ;
SIMPSON, E ;
TOMONARI, K .
NATURE, 1991, 349 (6309) :531-532
[9]   Prolonged acceptance of concordant and discordant xenografts with combined CD40 and CD28 pathway blockade [J].
Elwood, ET ;
Larsen, CP ;
Cho, HR ;
Corbascio, M ;
Ritchie, SC ;
Alexander, DZ ;
Tucker-Burden, C ;
Linsley, PS ;
Aruffo, A ;
Hollenbaugh, D ;
Winn, KJ ;
Pearson, TC .
TRANSPLANTATION, 1998, 65 (11) :1422-1428
[10]   AN ESSENTIAL ROLE FOR GP39, THE LIGAND FOR CD40, IN THYMIC SELECTION [J].
FOY, TM ;
PAGE, DM ;
WALDSCHMIDT, TJ ;
SCHONEVELD, A ;
LAMAN, JD ;
MASTERS, SR ;
TYGRETT, L ;
LEDBETTER, JA ;
ARUFFO, A ;
CLASSEN, E ;
XU, JCC ;
FLAVELL, RA ;
OEHEN, S ;
HEDRICK, SM ;
NOELLE, RJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (05) :1377-1388